Fact CheckerSign in

NCT05823558Completed

Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients

Source: ClinicalTrials.gov · Last updated 4 Nov 2024

Brief summary (registry, in English)

In osteoporosis, sarcopenia is a common condition. Sarcopenic measurements can be made by evaluating muscle thickness in different regions. We aim to evaluate lumbar muscle losses in patients with osteoporosis in the lumbar region and to examine whether these muscle losses are correlated with the level of osteoporosis. The patients will be divided into 3 groups as healthy, osteopenic and osteoporotic according to DEXA measurements. Demographic values, comorbidities, osteoporosis drugs used, fracture histories, L1-4, L2-4, femoral neck and total BMD and t values of the patients, psoas and multifidus muscle measurements will be made at L2-L3 level in Lumbar MR imaging. Lumbar MR muscle measurements will be made by 1 physician blind to the DEXA values of the patients.

Status (registry)
Completed
Study type
Observational
Enrollment
301 (actual)
First submitted
10 Apr 2023
Start date
15 Aug 2023
Primary completion date
15 Aug 2024
Lead sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Diseases
Osteoporosis
NCT number
NCT05823558

What you commit to

  • Study type: Observational
  • Participants enrolled: 301
  • From 15 Aug 2023 to the primary completion date, 15 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have had previous lumbar surgery
  • Any previous lumbar injection

Other

  • Stage 3-4 Lumbar Listesis
  • Presence of Lumbar Discopathy accompanied by neurological deficit

Who the study is looking for

  • 50-90 years old
  • 2\. Recent MRI of the lumbar region with DEXA evaluation

Age in the registry: 50 years to 90 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Etfal Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.